Nihon Kohden (NHNKY) Set to Announce Earnings on Tuesday

Key Points

• Nihon Kohden is expected to report earnings after the market closes Tuesday, November 10. Analysts forecast quarterly EPS of $0.17 and revenue of $352.12 million.
• The company’s previous quarter fell short of expectations, reporting a loss of $0.03 per share versus the $0.06 consensus estimate and revenue of $297.47 million.
• Shares recently traded at $10.06, while analyst sentiment remains cautious: UBS downgraded the stock to “Hold,” and the overall consensus rating is “Hold.”

Nihon Kohden (OTCMKTS:NHNKY - Get Free Report) is anticipated to release its results after the market closes on Tuesday, November 10th. Analysts expect the company to announce earnings of $0.17 per share and revenue of $352.12 million for the quarter.

Nihon Kohden (OTCMKTS:NHNKY - Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported ($0.03) EPS for the quarter, missing the consensus estimate of $0.06 by ($0.09). Nihon Kohden had a return on equity of 9.17% and a net margin of 5.90%. The business had revenue of $297.47 million during the quarter, compared to the consensus estimate of $299.98 million. On average, analysts expect Nihon Kohden to post $0.60 EPS for the current fiscal year and $0.66 EPS for the next fiscal year.

Nihon Kohden Price Performance

OTCMKTS NHNKY traded down $0.10 on Tuesday, reaching $10.06. The company's stock had a trading volume of 212 shares, compared to its average volume of 22,260. Nihon Kohden has a twelve month low of $8.12 and a twelve month high of $13.61. The company has a debt-to-equity ratio of 0.12, a quick ratio of 2.64 and a current ratio of 3.98. The firm's 50 day moving average is $10.00 and its two-hundred day moving average is $9.82. The stock has a market cap of $1.69 billion, a PE ratio of 18.29 and a beta of 0.38.

Wall Street Analyst Weigh In

Separately, UBS Group downgraded shares of Nihon Kohden from a "strong-buy" rating to a "hold" rating in a report on Wednesday, August 12th. Two investment analysts have rated the stock with a Hold rating. According to MarketBeat, Nihon Kohden currently has an average rating of "Hold".

About Nihon Kohden

Nihon Kohden Corporation is a Japanese medical technology company that develops, manufactures and markets electronic medical equipment and related solutions. Founded in 1951 and headquartered in Tokyo, the company serves hospitals, clinics and other healthcare providers through operations in Japan and international markets.

Its product portfolio includes patient monitoring systems, electrocardiographs, electroencephalographs and other neurological diagnostic equipment. Nihon Kohden also supplies defibrillators, automated external defibrillators, ventilators, anesthesia-related equipment, clinical information systems and devices used in in-vitro diagnostics, including hematology testing.

The company distributes its products through domestic and overseas subsidiaries, distributors and service networks.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.